The European Medicines Agency may issue its decision on Moderna vaccine Monday.
The European Medicines Agency announced that it may decide later on Monday whether to approve the use of Moderna's vaccine against the emerging corona virus, instead of the previous date, Wednesday.
The Amsterdam-based European Union agency had submitted the decision date for the date originally scheduled for Wednesday, January 12, under pressure from European Union countries with the high number of HIV infections. "There is a meeting of the Medicines Committee of the European Medicines Agency today, Monday, January 4th, to discuss the moderna vaccine," the agency said in a statement.
She explained that it would issue a statement as soon as "in the event that the Human Medicines Committee reaches an opinion at today's meeting." She added that if she fails to make a decision on a conditional one-year marketing permit for the Moderna vaccine, she will meet again Wednesday. Reports indicated that the Moderna vaccine in the United States is 94.1 percent effective in preventing Covid-19, in a clinical trial that included 30,400 people.
If approved, it will be the second vaccine for Moderna in this regard in the European Union, after the agency gave the green light to the Pfizer / Biontech vaccine in another decision taken on December 21.
|Related Link: Click here to visit item owner's website (0 hit)|
|Target State: New York|
Target City : All Cities
Last Update : Jan 04, 2021 4:08 PM
Number of Views: 10
|Item Owner : VACCINE|
Contact Email: (None)
Contact Phone: (None)
|Friendly reminder: Click here to read some tips.|